Pallavi Kishor Vawhal

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 4

Top Topics

Cardiovascular Risk Factors

Emergency Department

Top Venues

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Pallavi Kishor Vawhal, Shailaja B Jadhav, Sumit Kaushik, Kahnu Charan Panigrahi, Chandan Nayak, Humaira Urmee, Sharuk L Khan, Falak A Siddiqui, Fahadul Islam, Aziz Eftekhari, Abdullah R Alzahrani, Mohd Fahami Nur Azlina, Md Moklesur Rahman Sarker, Ibrahim Abdel Aziz Ibrahim
Coumarin-Based Sulfonamide Derivatives as Potential DPP-IV Inhibitors: Pre-ADME Analysis, Toxicity Profile, Computational Analysis, and In Vitro Enzyme Assay. Molecules (Basel, Switzerland) 28 (3) (2023)
Pallavi Kishor Vawhal, Shailaja B Jadhav, Sumit Kaushik, Kahnu Charan Panigrahi, Chandan Nayak, Humaira Urmee, Sharuk L Khan, Falak A Siddiqui, Fahadul Islam, Aziz Eftekhari, Abdullah R Alzahrani, Mohd Fahami Nur Azlina, Md Moklesur Rahman Sarker, Ibrahim Abdel Aziz Ibrahim
Coumarin-Based Sulfonamide Derivatives as Potential DPP-IV Inhibitors: Pre-ADME Analysis, Toxicity Profile, Computational Analysis, and In Vitro Enzyme Assay. Molecules (Basel, Switzerland) 28 (3) (2023)
Pallavi Kishor Vawhal, Shailaja B Jadhav, Sumit Kaushik, Kahnu Charan Panigrahi, Chandan Nayak, Humaira Urmee, Sharuk L Khan, Falak A Siddiqui, Fahadul Islam, Aziz Eftekhari, Abdullah R Alzahrani, Mohd Fahami Nur Azlina, Md Moklesur Rahman Sarker, Ibrahim Abdel Aziz Ibrahim
Coumarin-Based Sulfonamide Derivatives as Potential DPP-IV Inhibitors: Pre-ADME Analysis, Toxicity Profile, Computational Analysis, and In Vitro Enzyme Assay. Molecules (Basel, Switzerland) 28 (3) (2023)
Pallavi Kishor Vawhal, Shailaja B Jadhav, Sumit Kaushik, Kahnu Charan Panigrahi, Chandan Nayak, Humaira Urmee, Sharuk L Khan, Falak A Siddiqui, Fahadul Islam, Aziz Eftekhari, Abdullah R Alzahrani, Mohd Fahami Nur Azlina, Md Moklesur Rahman Sarker, Ibrahim Abdel Aziz Ibrahim
Coumarin-Based Sulfonamide Derivatives as Potential DPP-IV Inhibitors: Pre-ADME Analysis, Toxicity Profile, Computational Analysis, and In Vitro Enzyme Assay. Molecules (Basel, Switzerland) 28 (3) (2023)